SWOT Analysis for Hamps Bio Ltd.

MACD Crossover Above Signal Line
Positive Breakout Third Resistance ( LTP > R3)
Relative Outperformance versus Industry over 1 Month
Stocks gaining versus previous close, open price and RSI
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Stock gained more than 20% in one month
RSI indicating price strength
MACD crossed above signal line previous end of day
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects
PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Low Piotroski Score : Companies with weak financials
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV